Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Cytokines are a protein family comprising interleukins, lymphokines, chemokines, monokines and interferons. They are significant constituents of the immune system, and they act in accordance with specific cytokine inhibiting compounds and receptors for the regulation of immune responses. Cytokine studies have resulted in the establishment of newer therapies which are being utilized for the treatment of several malignant diseases. The advancement of these therapies has occurred from two distinct strategies. The first strategy involves administrating the recombinant and purified cytokines, and the second strategy involves administrating the therapeutics which inhibits harmful effects of endogenous and overexpressed cytokines. Colony stimulating factors and interferons are two exemplary therapeutics of cytokines. An important effect of cytokine receptor antagonist is that they can serve as anti-inflammatory agents by altering the treatments of inflammation disorder, therefore inhibiting the effects of tumour necrosis factor. In this article, we have highlighted the research behind the establishment of cytokines as therapeutics and vaccine adjuvants, their role of immunotolerance, and their limitations. Copyright © 2023 Elsevier Ltd. All rights reserved.

Citation

Tanjilur Rahman, Ayan Das, Mehedy Hasan Abir, Iqbal Hossain Nafiz, Aar Rafi Mahmud, Md Rifat Sarker, Talha Bin Emran, Mohammad Mahmudul Hassan. Cytokines and their role as immunotherapeutics and vaccine Adjuvants: The emerging concepts. Cytokine. 2023 Sep;169:156268

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 37320965

View Full Text